1. Home
  2. NWBI vs ANIP Comparison

NWBI vs ANIP Comparison

Compare NWBI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Bancshares Inc.

NWBI

Northwest Bancshares Inc.

HOLD

Current Price

$12.48

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$80.78

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWBI
ANIP
Founded
1896
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NWBI
ANIP
Price
$12.48
$80.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$15.00
$102.14
AVG Volume (30 Days)
868.2K
438.9K
Earning Date
01-23-2026
11-07-2025
Dividend Yield
6.54%
N/A
EPS Growth
13.78
N/A
EPS
0.86
1.67
Revenue
$564,562,000.00
$826,880,000.00
Revenue This Year
$7.91
$43.41
Revenue Next Year
$9.01
$9.66
P/E Ratio
$14.16
$49.04
Revenue Growth
15.71
48.87
52 Week Low
$10.75
$52.50
52 Week High
$14.64
$99.50

Technical Indicators

Market Signals
Indicator
NWBI
ANIP
Relative Strength Index (RSI) 60.81 36.17
Support Level $12.14 $80.57
Resistance Level $12.54 $83.60
Average True Range (ATR) 0.24 2.45
MACD 0.08 0.16
Stochastic Oscillator 96.43 38.91

Price Performance

Historical Comparison
NWBI
ANIP

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: